Update: Adds company statement about Ozempic availability in the U.S. Novo Nordisk (NVO) has said in a note published by the European Medicines Agency that the supply shortage of its diabetes drug ...

It also provides other contract manufacturing services. Novo Holdings, the investment firm that has a controlling interest in Novo Nordisk, signed a $16.5 billion deal to buy Catalent in February ...

However, other studies have reached the opposite conclusion. Novo Nordisk's crown jewel is safe for now, and continues to drive its financial results higher. However, various potential headwinds ...

This is especially helpful in biomedicine, where de ... novo protein design and protein optimisation (see Table 1). Some companies, such as Arzeda and AI Proteins, provide a good option for ...

Whether large or small, buy- or sell-focused, organizations focused on growth should explore acquisition and de novo development strategies. Aligning the right and best growth strategy with your ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Biotechnology and pharmaceutical companies are now investing largely in developing innovative technologies for nucleotide synthesis. · For example, in March 2023 Integrated DNA Technologies (IDT) made ...